Mitral/Tricuspid Valvular Disease - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study
Mitral Valve Remodeling and Strain in Secondary Mitral Regurgitation: Comparison With Primary Regurgitation and Normal Valves
Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial
Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years
Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry

Recommandation Statement

18 March 2021

JOURNAL：Eur Heart J.

The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

AJS Coats, SD Anker, A Baumbach et al.

6437

Keywords: functional mitral regurgitation; secondary mitral regurgitation; CHF

Full Text PDF